多参数磁共振成像鉴别活动性与非活动性甲状腺相关眼病:磁化传递成像的附加价值
该前瞻性研究纳入60例连续甲状腺相关眼病患者,分析眼眶磁化传递、脂肪饱和T2加权和扩散加权成像,计算眼外肌磁化传递率(MTR)、信号强度比(SIR)和表观扩散系数(ADC)的简化直方图参数。活动性甲状腺相关眼病患者MTRmean较低而SIRs和ADCs较高,MTRmean鉴别活动性的AUC达0.868,且与临床活动评分(CAS)呈负相关(r=-0.614,P<0.001);支持向量机分析显示联合MTRs较仅联合SIRs和ADCs对疾病活动性鉴别和CAS预测的AUC更高(0.933 vs 0.901)。
要点
- 活动性甲状腺相关眼病眼外肌MTRmean较低,SIRs和ADCs较高。
- MTRmean鉴别活动性与非活动性AUC为0.868,优于SIRmax的0.836。
- MTRmean与CAS呈负相关(r=-0.614,P<0.001)。
核心结论
- 磁化传递成像可能作为一种无创方法用于鉴别甲状腺相关眼病活动性和预测CAS,为常规SIR和ADC提供附加价值。
研究设计与样本
- 前瞻性纳入60例连续甲状腺相关眼病患者,分析眼眶磁化传递、脂肪饱和T2加权和扩散加权成像,计算眼外肌MTR、SIR和ADC的简化直方图参数(均值、最大值、最小值),比较活动性与非活动性组。
关键影像表现/征象
- 活动性甲状腺相关眼病患者眼外肌MTRs显著低于非活动性组,SIRs和ADCs显著高于非活动性组(P<0.05)。
- MTRs和SIRs的组内相关系数相似(分别为0.802-0.963和0.812-0.974),ADCs的组内相关系数为0.714-0.855。
诊断标准与关键数值
- MTRmean鉴别活动性与非活动性甲状腺相关眼病的AUC为0.868,SIRmax的AUC为0.836。
- MTRmean与CAS呈负相关(r=-0.614,P<0.001),MTRmax和MTRmin与CAS的相关系数分别为r=-0.495(P<0.001)和r=-0.243(P=0.007)。
- 支持向量机分析显示联合MTRs较仅联合SIRs和ADCs的AUC更高(0.933 vs 0.901),与CAS的相关系数分别为r=0.703 vs r=0.673。
临床应用与阅片要点
- 磁化传递成像的MTRmean可作为鉴别甲状腺相关眼病活动性的影像指标,其AUC高于SIRmax。
- MTRmean与CAS呈负相关,可能有助于预测临床活动评分。
- 联合MTRs较仅联合SIRs和ADCs对疾病活动性鉴别和CAS预测的性能更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate the feasibility of using magnetization transfer (MT) magnetic resonance imaging for evaluating patients with thyroid-associated ophthalmopathy (TAO), and determine its added value for differentiating active from inactive TAO and predicting clinical activity score (CAS), compared with conventional fat-saturated T2-weighted and diffusion-weighted imaging.
METHODS: Orbital MT, fat-saturated T2-weighted, and diffusion-weighted imaging of 60 prospectively enrolled consecutive patients with TAO was analyzed. Simplified histogram parameters (mean, max, min) of magnetization transfer ratio (MTR), signal intensity ratio (SIR), and apparent diffusion coefficient (ADC) at extraocular muscles were calculated for each orbit and compared between the active and inactive groups.
RESULTS: Intraclass correlation coefficients of MTRs and SIRs were similar (0.802-0.963 vs 0.812-0.974, respectively), followed by those of ADCs (0.714-0.855). Patients with active TAO showed significantly lower MTRs and higher SIRs and ADCs than those with inactive TAO (P < 0.05). MTRmean achieved the highest area under the curve (AUC) of 0.868 for differentiating active from inactive group, followed by SIRmax (AUC, 0.836). MTRmean also demonstrated a higher and negative correlation with CAS (r = -0.614, P < 0.001) than MTRmax and MTRmin (r = -0.495, P < 0.001; r = -0.243, P = 0.007; respectively). Support vector machine-based analysis revealed that uniting MTRs could prosper concurrently added performance for disease activity differentiation and CAS prediction, compared with merely combining SIRs and ADCs (AUC, 0.933 vs 0.901; r = 0.703 vs. 0.673).
CONCLUSIONS: MT imaging could potentially be used as a noninvasive method for differentiating the activity of TAO and predicting CAS, thereby offering added value to conventional SIR and ADC.
引用
- Hu, Chen, Zhou, et al. Multiparametric magnetic resonance imaging for differentiating active from inactive thyroid-associated ophthalmopathy: Added value from magnetization transfer imaging. Eur J Radiol. 2022. PMID: 35405579. doi:10.1016/j.ejrad.2022.110295
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。